Opko Health (OPK) Common Equity (2010 - 2026)

Opko Health has reported Common Equity for 17 years, with the latest figure at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 8.16% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (down 8.16% YoY), and the FY2025 full-year result was $1.3 billion, down 7.14% from the prior year.
• Common Equity for Q1 2026 stood at $1.2 billion, down from $1.3 billion in the prior quarter.
• The five-year high for Common Equity was $1.7 billion in Q2 2022, with the low at $1.2 billion in Q1 2026.
• Historically, Common Equity has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2024.
• Annual changes were most pronounced in 2024 — Common Equity decreased 19.27% — and 2025, when it rose 4.7%.
• Opko Health's Common Equity stood at $1.6 billion in 2022, then fell by 11.04% to $1.4 billion in 2023, then declined by 1.71% to $1.4 billion in 2024, then dropped by 7.14% to $1.3 billion in 2025, then slipped by 5.0% to $1.2 billion in 2026.
• The last three Common Equity figures came in at $1.2 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.